A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
Status:
Completed
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo-controlled withdrawal and rescue/restoration
study in subjects with endogenous CS previously treated with single-arm, open-label
levoketoconazole that will assess efficacy, safety, tolerability, and pharmacokinetics of
levoketoconazole.